Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PRIZE: Switching to Semiannual Leuprorelin in Prostate Cancer
NCT05304169Phase 4Completed
- Sponsor
- Zodiac Produtos Farmacêuticos
- Start
- Nov 2017
- Primary completion
- Jun 2018
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of leuprolide in prostate cancer (PCa), sponsored by Zodiac Produtos Farmacêuticos. Started Nov 2017; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT05304169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05304169.